Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
Cancer of the Cervix, Vulvar Cancer, Esophageal Cancer
About this trial
This is an interventional other trial for Cancer of the Cervix
Eligibility Criteria
Inclusion Criteria:
Pathologically (histologically or cytologically) proven diagnosis of cervical, vulvar, esophageal and anal canal cancer
Patients with local or regional nodal disease are eligible
Zubrod Performance Status 0, 1, or 2
Age ≥ 18
Negative serum pregnancy test for women of child bearing potential
Patient must sign study-specific informed consent prior to study entry
Exclusion Criteria:
No gross disease visible on imaging at the start of radiotherapy
Contraindication to PET
Complete response by PET achieved with pre-radiation therapy treatment (surgery or chemotherapy)
Breast feeding
Positive serum pregnancy test
Sites / Locations
- Duke University Medical CenterRecruiting
Arms of the Study
Arm 1
Other
Single arm interventional study
Research FDG-PET scan obtained before radiation therapy; a second research FDG-PET scan is obtained at about 3-5 weeks after treatment has started.